ABOUT RUBEDO
Powered by our drug discovery computational platform ALEMBIC™ and enabled by our proprietary chemistry engineering, Rubedo makes novel drugs designed to be selective, safe and well tolerated.
Rubedo’s lead small molecules are engineered to be selectively activated in pathological cells that drive age-related diseases.
NEWSFEED
Rubedo Life Sciences Closes $12M Seed Financing Led by Khosla Ventures
- December 3, 2020
- 3:32 pm
Rubedo listed among top senolytic companies in Nature Biotechnology
- November 17, 2020
- 8:20 pm
INVESTORS
CAREERS
We welcome all applicants regardless of gender, sexual orientation, ethnicity, race, education, age, or other personal characteristics
Rubedo Life Sciences , Inc
Silicon Valley, CA, USA
Copyright 2020 by Rubedo Life Sciences, inc